Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 106 citing articles:

EASL recommendations on treatment of hepatitis C: Final update of the series☆
Jean‐Michel Pawlotsky, Francesco Negro, Alessio Aghemo, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1170-1218
Closed Access | Times Cited: 968
Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement
R. Graham Barr, Stephanie R. Wilson, Deborah J. Rubens, et al.
Radiology (2020) Vol. 296, Iss. 2, pp. 263-274
Closed Access | Times Cited: 346
Hepatitis C
C. Wendy Spearman, Geoffrey Dusheiko, Margaret Hellard, et al.
The Lancet (2019) Vol. 394, Iss. 10207, pp. 1451-1466
Closed Access | Times Cited: 333
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Jian Zhou, Hui–Chuan Sun, Zheng Wang, et al.
Liver Cancer (2023) Vol. 12, Iss. 5, pp. 405-444
Open Access | Times Cited: 182
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals
Mònica Pons, Sergio Rodríguez‐Tajes, Juan Ignacio Esteban, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 3, pp. 472-480
Closed Access | Times Cited: 173
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
Amit G. Singal, Nicole E. Rich, Neil Mehta, et al.
Gastroenterology (2019) Vol. 157, Iss. 5, pp. 1253-1263.e2
Open Access | Times Cited: 163
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Don C. Rockey, Scott L. Friedman
Gastroenterology (2021) Vol. 160, Iss. 5, pp. 1502-1520.e1
Open Access | Times Cited: 105
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
Abid Suddle, Helen L. Reeves, Richard Hubner, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1235-1268
Open Access | Times Cited: 18
<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>
Srikanta Dash, Yücel Aydın, Kyle E Widmer, et al.
Journal of Hepatocellular Carcinoma (2020) Vol. Volume 7, pp. 45-76
Open Access | Times Cited: 91
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Víctor Sapena, Marco Enea, Ferrán Torres, et al.
Gut (2021) Vol. 71, Iss. 3, pp. 593-604
Open Access | Times Cited: 85
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis
Sonia Alonso López, María Luisa Manzano, Francisco Gea, et al.
Hepatology (2020) Vol. 72, Iss. 6, pp. 1924-1934
Closed Access | Times Cited: 80
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 500-500
Open Access | Times Cited: 56
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Wojciech Straś, Dariusz Wasiak, B Łągiewska, et al.
Annals of Transplantation (2022) Vol. 27
Open Access | Times Cited: 43
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska, Michał Brzdęk, Piotr Rzymski, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 833-852
Closed Access | Times Cited: 9
Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma
Daisuke Uchida, Akinobu Takaki, Atsushi Oyama, et al.
Nutrients (2020) Vol. 12, Iss. 6, pp. 1576-1576
Open Access | Times Cited: 59
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
Yasuhito Tanaka, Eiichi Ogawa, Chung‐Feng Huang, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 1023-1033
Closed Access | Times Cited: 56
Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management
Han Wu, Ming‐Da Wang, Lei Liang, et al.
Small (2021) Vol. 17, Iss. 6
Closed Access | Times Cited: 41
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis
Brian L. Pearlman
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1551-1561
Closed Access | Times Cited: 6
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma
Edoardo G. Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access
DAA‐PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
Amit G. Singal, K. Rajender Reddy, Massimo Colombo, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 2
Closed Access
Models to Predict Development or Recurence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Hepatic Fibrosis
Mignote Yilma, Varun Saxena, Neil Mehta
Current Gastroenterology Reports (2022) Vol. 24, Iss. 1, pp. 1-9
Open Access | Times Cited: 20
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study
Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 166-166
Open Access | Times Cited: 12
Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation
Kuo‐Cheng Wu, I‐Cheng Lee, Chen‐Ta Chi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 7, pp. 940-952
Open Access | Times Cited: 4
Hepatocellular Carcinoma in Patients with Chronic Hepatitis C and Liver Cirrhosis Treated with DAA: A Focused Review
Săndica Bucurică, Andreea-Simona Nancoff, Raluca Ioana Marin, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1505-1505
Open Access
Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma
Yuko Nagaoki, Kenji Yamaoka, Yasutoshi Fujii, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Page 1 - Next Page

Scroll to top